Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD

Kidney360. 2022 Mar 2;3(5):859-871. doi: 10.34067/KID.0006222021. eCollection 2022 May 26.

Abstract

Background: Several cardiac biomarkers of cardiac stress, inflammation, and fibrosis (N-terminal pro brain-type natriuretic peptide [NT-proBNP], high-sensitivity troponin T [hsTnT], growth differentiation factor 15 [GDF-15], and soluble ST2 [sST2]) have been associated with atherosclerotic disease in the general population. We hypothesized that these cardiac biomarkers may also be associated with the atherosclerotic cardiovascular disease in patients with CKD.

Methods: We analyzed levels of NT-proBNP, hsTnT, GDF-15, and sST2 in a cohort of 2732 participants with mild to moderate CKD from the Chronic Renal Insufficiency Cohort (CRIC) study. Outcomes included incident atherosclerotic disease, defined as the first instance of myocardial infarction, stroke, or peripheral vascular disease. We used Cox proportional hazard models to the test the association of each cardiac biomarker with risk of incident atherosclerotic disease, adjusting for multiple possible confounders.

Results: When modeled continuously (per SD increase in the log-transformed biomarker), NT-proBNP, hsTnT, GDF-15, and sST2 were significantly associated with incident atherosclerotic disease after adjustment for multiple potential confounders: (NT-proBNP HR, 1.51; 95% CI, 1.27 to 1.81; hsTnT HR, 1.61; 95% CI, 1.38 to 1.89; GDF-15 HR, 1.44; 95% CI, 1.19 to 1.73; and sST2 HR, 1.19; 95% CI, 1.04 to 1.36).

Conclusions: NT-proBNP, hsTnT, GDF-15, and sST2 were significantly associated with incident atherosclerotic cardiovascular disease in patients with CKD. These associations may highlight important mechanisms for the development of atherosclerotic disease in CKD.

Keywords: GDF-15; NT-proBNP; atherosclerosis; biomarkers; cardiovascular disease; chronic kidney disease; hsTnT; sST2.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Atherosclerosis* / diagnosis
  • Biomarkers
  • Cardiovascular Diseases* / diagnosis
  • Growth Differentiation Factor 15
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein
  • Renal Insufficiency, Chronic* / diagnosis
  • Troponin T

Substances

  • Biomarkers
  • Growth Differentiation Factor 15
  • Interleukin-1 Receptor-Like 1 Protein
  • Troponin T